Lebman DA - Search Results

1

Mechanism of resistance to phagocytosis and pulmonary persistence in mucoid Pseudomonas aeruginosa.

Rowe WJ 3rd, Lebman DA, Ohman DE. Rowe WJ 3rd, et al. Among authors: lebman da. Front Cell Infect Microbiol. 2023 Mar 15;13:1125901. doi: 10.3389/fcimb.2023.1125901. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37009499 Free PMC article.

2

Gene expression of the lysophosphatidic acid receptor 1 is a target of transforming growth factor beta.

Wu J, Mukherjee A, Lebman DA, Fang X. Wu J, et al. Among authors: lebman da. Oncogene. 2013 Jun 27;32(26):3198-206. doi: 10.1038/onc.2012.325. Epub 2012 Jul 23. Oncogene. 2013. PMID: 22824789 Free PMC article.

3

Photocaged permeability: a new strategy for controlled drug release.

Dcona MM, Mitra D, Goehe RW, Gewirtz DA, Lebman DA, Hartman MC. Dcona MM, et al. Among authors: lebman da. Chem Commun (Camb). 2012 May 16;48(39):4755-7. doi: 10.1039/c2cc30819c. Epub 2012 Apr 4. Chem Commun (Camb). 2012. PMID: 22473358 Free PMC article.

4

Lysophosphatidic acid-induced p21Waf1 expression mediates the cytostatic response of breast and ovarian cancer cells to TGFβ.

Wu J, Mukherjee A, Lebman DA, Fang X. Wu J, et al. Among authors: lebman da. Mol Cancer Res. 2011 Nov;9(11):1562-70. doi: 10.1158/1541-7786.MCR-11-0340. Epub 2011 Sep 2. Mol Cancer Res. 2011. PMID: 21890597 Free PMC article.

5

Preservation of splenic immunocompetence after splenic artery angioembolization for blunt splenic injury.

Malhotra AK, Carter RF, Lebman DA, Carter DS, Riaz OJ, Aboutanos MB, Duane TM, Ivatury RR. Malhotra AK, et al. Among authors: lebman da. J Trauma. 2010 Nov;69(5):1126-30; discussion 1130-1. doi: 10.1097/TA.0b013e3181f9fa1e. J Trauma. 2010. PMID: 21068617

6

Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery.

Holden CA, Yuan Q, Yeudall WA, Lebman DA, Yang H. Holden CA, et al. Among authors: lebman da. Int J Nanomedicine. 2010 Feb 2;5:25-36. Int J Nanomedicine. 2010. PMID: 20161985 Free PMC article.

7

Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 1989. 170: 1039-1044.

Coffman RL, Lebman DA, Shrader B. Coffman RL, et al. Among authors: lebman da. J Immunol. 2009 Jan 1;182(1):8-13. J Immunol. 2009. PMID: 19109127 No abstract available.

8

Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells.

Miller AV, Alvarez SE, Spiegel S, Lebman DA. Miller AV, et al. Among authors: lebman da. Mol Cell Biol. 2008 Jun;28(12):4142-51. doi: 10.1128/MCB.01465-07. Epub 2008 Apr 21. Mol Cell Biol. 2008. PMID: 18426913 Free PMC article.

9

Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling.

Lebman DA, Spiegel S. Lebman DA, et al. J Lipid Res. 2008 Jul;49(7):1388-94. doi: 10.1194/jlr.R800008-JLR200. Epub 2008 Apr 2. J Lipid Res. 2008. PMID: 18387885 Free PMC article. Review.

10

Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.

Edmiston JS, Yeudall WA, Chung TD, Lebman DA. Edmiston JS, et al. Among authors: lebman da. Cancer Res. 2005 Jun 1;65(11):4782-8. doi: 10.1158/0008-5472.CAN-04-4354. Cancer Res. 2005. PMID: 15930298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters